Oruka Therapeutics (ORKA) Stock: Buy, Sell, or Hold?
ORKA - Oruka Therapeutics, Inc. Common Stock
$84.52
1.10 (1.32%)
▲
5d:
+0.07%
30d:
-7.76%
90d:
+1.67%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When ORKA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ORKA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ORKA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ORKA is currently trading at $84.52, which is considered oversold relative to its 30-day fair value range of $87.27 to $97.39.
Technical Outlook: Technically, ORKA is in a strong uptrend. Immediate support is located at $81.11, while resistance sits at $96.78.
Market Sentiment: ORKA scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $155.00 (+83.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ORKA is in a strong uptrend. Immediate support is located at $81.11, while resistance sits at $96.78.
Market Sentiment: ORKA scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $155.00 (+83.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$87.27 -
$97.39
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (61/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 83.4% below Wall St target ($155.00)
- CAUTION: Bottoming setup, but lagging the sector by 21% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$87.27 -
$97.39
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$81.11
Resistance Level
$96.78
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-29.53
Wall Street Target
$155.00
(+83.4%)
Share & Embed Analysis
Last updated: October 03, 2026 4:02 AM ET
Data refreshes hourly during market hours. Next update: 5:02 AM
Data refreshes hourly during market hours. Next update: 5:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORKA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Joana Goncalves
SELL
7000 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 56 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 52 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 51 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
10 analysts |
$70 | 68 BUY |
